Skip to main content

Clinical development of oral oleylphosphocholine as a new drug for the treatment of Old World Cutaneous Leishmaniasis

Project description

A simple oral treatment for the neglected disease cutaneous leishmaniasis

Many diseases that are not life-threatening in developed countries, do not receive the resources and attention required to investigate prevention, treatment or cure. Cutaneous leishmaniasis (CL), caused by a parasite transmitted via infected sand flies, is one among them. Infections are common in low-income populations of developing regions. Producing ulcers, sometimes up to 200, on exposed parts of the body, CL can leave permanent scars that are often the source of extreme social prejudice. TT4CL is working hard to bring a promising oral treatment for CL into clinical trials. Registration with regulatory agencies requiring proof of conformance to stringent safety, efficacy and tolerability requirements could change the lives of millions of people globally.

Call for proposal

H2020-SC1-2018-Two-Stage-RTD
See other projects for this call

Coordinator

ST GEORGE'S HOSPITAL MEDICAL SCHOOL
Address
Cranmer Terrace
SW17 0RE London
United Kingdom
Activity type
Higher or Secondary Education Establishments
EU contribution
€ 1 143 863,88

Participants (6)

OBLITA THERAPEUTICS
Belgium
EU contribution
€ 367 550
Address
Rodendijk 40
2980 Zoersel
Activity type
Private for-profit entities (excluding Higher or Secondary Education Establishments)
LONDON SCHOOL OF HYGIENE AND TROPICAL MEDICINE ROYAL CHARTER
United Kingdom
EU contribution
€ 390 568,08
Address
Keppel Street
WC1E 7HT London
Activity type
Higher or Secondary Education Establishments
AVIVIA BEHEER BV
Netherlands
EU contribution
€ 591 000
Address
Transistorweg 5
6534AT Nijmegen
Activity type
Private for-profit entities (excluding Higher or Secondary Education Establishments)
EBERHARD KARLS UNIVERSITAET TUEBINGEN
Germany
EU contribution
€ 710 150,01
Address
Geschwister-scholl-platz
72074 Tuebingen
Activity type
Higher or Secondary Education Establishments
TEHRAN UNIVERSITY OF MEDICAL SCIENCES
Iran
EU contribution
€ 371 375,55
Address
Office Of Vice Chancellor For Global Strategies An International Affairs No 21 Dameshgh St Vali E Asr Ave
1416753955 Tehran
Activity type
Higher or Secondary Education Establishments
UNIVERSITY OF YORK
United Kingdom
EU contribution
€ 178 628,04
Address
Heslington
YO10 5DD York North Yorkshire
Activity type
Higher or Secondary Education Establishments